These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 16039021)

  • 1. Investigation of non-typeable Haemophilus influenzae outer membrane protein P6 as a new carrier for lipooligosaccharide conjugate vaccines.
    Wu T; Chen J; Murphy TF; Green BA; Gu XX
    Vaccine; 2005 Oct; 23(44):5177-85. PubMed ID: 16039021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploration of Moraxella catarrhalis outer membrane proteins, CD and UspA, as new carriers for lipooligosaccharide-based conjugates.
    Hu WG; Berry J; Chen J; Gu XX
    FEMS Immunol Med Microbiol; 2004 Jun; 41(2):109-15. PubMed ID: 15145454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outer membrane proteins as a carrier for detoxified lipooligosaccharide conjugate vaccines for nontypeable Haemophilus influenzae.
    Wu TH; Gu XX
    Infect Immun; 1999 Oct; 67(10):5508-13. PubMed ID: 10496940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A recombinant P4 protein of Haemophilus influenzae induces specific immune responses biologically active against nasopharyngeal colonization in mice after intranasal immunization.
    Hotomi M; Ikeda Y; Suzumoto M; Yamauchi K; Green BA; Zlotnick G; Billal DS; Shimada J; Fujihara K; Yamanaka N
    Vaccine; 2005 Jan; 23(10):1294-300. PubMed ID: 15652672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and characterization of lipooligosaccharide-based conjugate vaccines for serotype B Moraxella catarrhalis.
    Yu S; Gu XX
    Infect Immun; 2005 May; 73(5):2790-6. PubMed ID: 15845482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biological and immunological characteristics of lipooligosaccharide-based conjugate vaccines for serotype C Moraxella catarrhalis.
    Yu S; Gu XX
    Infect Immun; 2007 Jun; 75(6):2974-80. PubMed ID: 17371852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis, characterization, and immunologic properties of detoxified lipooligosaccharide from nontypeable Haemophilus influenzae conjugated to proteins.
    Gu XX; Tsai CM; Ueyama T; Barenkamp SJ; Robbins JB; Lim DJ
    Infect Immun; 1996 Oct; 64(10):4047-53. PubMed ID: 8926067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maternal intranasal immunization with outer membrane protein P6 maintains specific antibody level of derived offspring.
    Yamauchi K; Hotomi M; Billal DS; Suzumoto M; Yamanaka N
    Vaccine; 2006 Jun; 24(25):5294-9. PubMed ID: 16697503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunogenicity of a Haemophilus influenzae polysaccharide-Neisseria meningitidis outer membrane protein complex conjugate vaccine.
    Donnelly JJ; Deck RR; Liu MA
    J Immunol; 1990 Nov; 145(9):3071-9. PubMed ID: 2120344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intranasal immunization with a lipooligosaccharide-based conjugate vaccine from nontypeable Haemophilus influenzae enhances bacterial clearance in mouse nasopharynx.
    Hirano T; Hou Y; Jiao X; Gu XX
    FEMS Immunol Med Microbiol; 2003 Jan; 35(1):1-10. PubMed ID: 12589951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and characterization of lipooligosaccharide-based conjugates as vaccine candidates for Moraxella (Branhamella) catarrhalis.
    Gu XX; Chen J; Barenkamp SJ; Robbins JB; Tsai CM; Lim DJ; Battey J
    Infect Immun; 1998 May; 66(5):1891-7. PubMed ID: 9573066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outer membrane vesicles (OMVs) and detoxified lipooligosaccharide (dLOS) obtained from Brazilian prevalent N. meningitidis serogroup B strains protect mice against homologous and heterologous meningococcal infection and septic shock.
    Jessouroun E; da Silveira IF; Larangeira AP; Pereira S; Fernandes SA; Rabinovitch L; Frasch CE; Castro-Faria-Neto HC; Bozza PT
    Vaccine; 2004 Jun; 22(20):2617-25. PubMed ID: 15193387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of an immunodominant T cell epitope of the P6 protein of nontypeable Haemophilus influenzae in murine protective immunity.
    McMahon M; Murphy TF; Kyd J; Thanavala Y
    Vaccine; 2005 May; 23(27):3590-6. PubMed ID: 15855018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Detection of LOS-specific antibody-secreting cells by ELISPOT assay].
    Jiao XA; Hirano T; Gu XX
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2004 May; 20(3):366-9. PubMed ID: 15193241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancement of clearance of bacteria from murine lungs by immunization with detoxified lipooligosaccharide from Moraxella catarrhalis conjugated to proteins.
    Hu WG; Chen J; Battey JF; Gu XX
    Infect Immun; 2000 Sep; 68(9):4980-5. PubMed ID: 10948114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Th17 cells contribute to nontypeable Haemophilus influenzae-specific protective immunity induced by nasal vaccination with P6 outer membrane protein and α-galactosylceramide.
    Noda K; Kodama S; Umemoto S; Nomi N; Hirano T; Suzuki M
    Microbiol Immunol; 2011 Aug; 55(8):574-81. PubMed ID: 21605159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduction of nasal colonization of nontypeable Haemophilus influenzae following intranasal immunization with rLP4/rLP6/UspA2 proteins combined with aqueous formulation of RC529.
    Mason KW; Zhu D; Scheuer CA; McMichael JC; Zlotnick GW; Green BA
    Vaccine; 2004 Sep; 22(25-26):3449-56. PubMed ID: 15308371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nasal immunization with plasmid DNA encoding P6 protein and immunostimulatory complexes elicits nontypeable Haemophilus influenzae-specific long-term mucosal immune responses in the nasopharynx.
    Kodama S; Hirano T; Noda K; Umemoto S; Suzuki M
    Vaccine; 2011 Feb; 29(10):1881-90. PubMed ID: 21237276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of peptide mimotopes of lipooligosaccharide from nontypeable Haemophilus influenzae as vaccine candidates.
    Hou Y; Gu XX
    J Immunol; 2003 Apr; 170(8):4373-9. PubMed ID: 12682274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunological characterisation of truncated lipooligosaccharide-outer membrane protein based conjugate vaccine against Moraxella catarrhalis and nontypeable Haemophilus influenzae.
    Singh S; Wilson JC; Cripps AW; Massa H; Ozberk V; Grice ID; Peak IR
    Vaccine; 2020 Jan; 38(2):309-317. PubMed ID: 31668366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.